Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barton F Haynes

Showing results (31-40 of 551) with videos related to

Pageof 56
Sort By:
Vaccines|June 17, 2014
Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune CorrelatesGeorgia D Tomaras, Barton F Haynes
Plos Pathogens|May 24, 2014
HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine developmentLaurent Verkoczy, Garnett Kelsoe, Barton F Haynes
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2014
Redemption of autoreactive B cellsBarton F Haynes, Laurent Verkoczy, Garnett Kelsoe
Vaccines|June 17, 2014
Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 AntibodiesGarnett Kelsoe, Laurent Verkoczy, Barton F Haynes
Current Opinion in Virology|November 6, 2021
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccinationZekun Mu, Barton F Haynes, Derek W Cain
Current Opinion in HIV and AIDS|October 17, 2017
Cross-reactivity of HIV vaccine responses and the microbiomeWilton B Williams, Qifeng Han, Barton F Haynes
Vaccines|February 10, 2021
HIV mRNA Vaccines-Progress and Future PathsZekun Mu, Barton F Haynes, Derek W Cain
Journal of Immunological Methods|January 30, 2010
Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clonesT Matt Holl, Barton F Haynes, Garnett Kelsoe
Current Opinion in HIV and AIDS|October 28, 2010
Is developing an HIV-1 vaccine possible?Barton F Haynes, Hua-Xin Liao, Georgia D Tomaras
Nature Structural & Molecular Biology|May 6, 2010
HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention?Barton F Haynes, Nathan I Nicely, S Munir Alam
Pageof 56

Showing results (31-40 of 551) with videos related to

Sort By:
Pageof 56
Vaccines|June 17, 2014
Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune CorrelatesGeorgia D Tomaras, Barton F Haynes
Plos Pathogens|May 24, 2014
HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine developmentLaurent Verkoczy, Garnett Kelsoe, Barton F Haynes
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2014
Redemption of autoreactive B cellsBarton F Haynes, Laurent Verkoczy, Garnett Kelsoe
Vaccines|June 17, 2014
Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 AntibodiesGarnett Kelsoe, Laurent Verkoczy, Barton F Haynes
Current Opinion in Virology|November 6, 2021
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccinationZekun Mu, Barton F Haynes, Derek W Cain
Current Opinion in HIV and AIDS|October 17, 2017
Cross-reactivity of HIV vaccine responses and the microbiomeWilton B Williams, Qifeng Han, Barton F Haynes
Vaccines|February 10, 2021
HIV mRNA Vaccines-Progress and Future PathsZekun Mu, Barton F Haynes, Derek W Cain
Journal of Immunological Methods|January 30, 2010
Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clonesT Matt Holl, Barton F Haynes, Garnett Kelsoe
Current Opinion in HIV and AIDS|October 28, 2010
Is developing an HIV-1 vaccine possible?Barton F Haynes, Hua-Xin Liao, Georgia D Tomaras
Nature Structural & Molecular Biology|May 6, 2010
HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention?Barton F Haynes, Nathan I Nicely, S Munir Alam
Pageof 56